Drug intelligence / Profile preview

Otodolor forte

Development stage: Unknown
Lead developer: Schwabe
Administration: Otic

Overview

Otodolor forte is a topical homeopathic ear drop formulation developed by Dr. Peithner KG (Austria). Its primary active ingredient is *Capsicum annuum*, derived from chili pepper, classifying it as a herbal or homeopathic preparation. It is indicated for the treatment of otitis externa, specifically addressing symptoms such as pain, irritation, redness, and eczematous incrustations of the external auditory canal, including infections associated with swimming (swimmer's ear). The product is administered topically into the affected ear. It has been evaluated in clinical studies alongside standard Otodolor eardrops for the management of external ear infections over a 14-day treatment period.

Brand names: Otodolor forteOtodolor forte Ohrentropfen

Beyond the preview

Go deeper on Otodolor forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Otodolor forte.

Explore the full profile